These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29976785)

  • 41. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initial patient choice of a growth hormone device improves child and adolescent adherence to and therapeutic effects of growth hormone replacement therapy.
    Gau M; Takasawa K
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):989-993. PubMed ID: 28771439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Final height in non-growth hormone deficient children treated with growth hormone. The Italian Multicentre Study Group.
    Bernasconi S; Street ME; Volta C; Mazzardo G
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):261-6; discussion 267. PubMed ID: 9373443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COMPLIA: A 12-MONTH PROSPECTIVE, MULTICENTRE, NON-INTERVENTIONAL STUDY TO EVALUATE TREATMENT ADHERENCE AND TREATMENT SATISFACTION IN A GROWTH HORMONE DEFICIENT PAEDIATRIC POPULATION TREATED WITH NUTROPINAQ
    Dumitrescu CP; Procopiuc C; Dumitriu N; Micle I; Anton M; Moisuc A
    Acta Endocrinol (Buchar); 2020; 16(2):192-198. PubMed ID: 33029236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3.
    Sävendahl L; Battelino T; Højby Rasmussen M; Brod M; Saenger P; Horikawa R
    J Clin Endocrinol Metab; 2022 Apr; 107(5):1357-1367. PubMed ID: 34964458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Safety and efficacy of growth hormone treatment: GeNeSIS study in Spain].
    Luzuriaga Tomás C; Oyarzabal Irigoyen M; Caveda Cepas E; Vázquez Salvi LA; García-Pérez LE;
    An Pediatr (Barc); 2016 Mar; 84(3):139-47. PubMed ID: 26139238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.
    Wallymahmed ME; Foy P; Shaw D; Hutcheon R; Edwards RH; MacFarlane IA
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):439-46. PubMed ID: 9404442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial.
    Benabbad I; Rosilio M; Child CJ; Carel JC; Ross JL; Deal CL; Drop SL; Zimmermann AG; Jia N; Quigley CA; Blum WF
    Horm Res Paediatr; 2017; 87(1):42-50. PubMed ID: 28002818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency.
    Reiter EO; Attie KM; Moshang T; Silverman BL; Kemp SF; Neuwirth RB; Ford KM; Saenger P;
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4700-6. PubMed ID: 11600528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adherence to growth hormone therapy: results of a multicenter study.
    Aydın BK; Aycan Z; Sıklar Z; Berberoğlu M; Ocal G; Cetinkaya S; Baş VN; Kendirci HN; Cetinkaya E; Darcan S; Gökşen D; Evliyaoğlu O; Sükür M; Baş F; Darendeliler F
    Endocr Pract; 2014 Jan; 20(1):46-51. PubMed ID: 24013997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is a Two-Year Growth Response to Growth Hormone Treatment a Better Predictor of Poor Adult Height Outcome Than a First-Year Growth Response in Prepubertal Children With Growth Hormone Deficiency?
    Straetemans S; Rooman R; De Schepper J
    Front Endocrinol (Lausanne); 2021; 12():678094. PubMed ID: 34140931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant human growth hormone treatment for dilated cardiomyopathy in children.
    McElhinney DB; Colan SD; Moran AM; Wypij D; Lin M; Majzoub JA; Crawford EC; Bartlett JM; McGrath EA; Newburger JW
    Pediatrics; 2004 Oct; 114(4):e452-8. PubMed ID: 15466071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth Hormone Injection Log Analysis with Electronic Injection Device for Qualifying Adherence to Low-Irritant Formulation and Exploring Influential Factors on Adherence.
    Takasawa K; Mabe H; Nagamatsu F; Amano N; Miyakawa Y; Sutani A; Kagawa R; Okada S; Tanahashi Y; Suzuki S; Hiroshima S; Nagasaki K; Dateki S; Takishima S; Takahashi I; Kashimada K
    Patient Prefer Adherence; 2023; 17():1885-1894. PubMed ID: 37545653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of real-world data on growth hormone therapy adherence using a connected injection device.
    Koledova E; Tornincasa V; van Dommelen P
    BMC Med Inform Decis Mak; 2020 Jul; 20(1):176. PubMed ID: 32727461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimizing Patient Management and Adherence for Children Receiving Growth Hormone.
    Acerini CL; Wac K; Bang P; Lehwalder D
    Front Endocrinol (Lausanne); 2017; 8():313. PubMed ID: 29209274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
    Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone.
    Giorgiani G; Bozzola M; Locatelli F; Picco P; Zecca M; Cisternino M; Dallorso S; Bonetti F; Dini G; Borrone C
    Blood; 1995 Jul; 86(2):825-31. PubMed ID: 7606014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A longitudinal study of craniofacial growth in idiopathic short stature and growth hormone-deficient boys treated with growth hormone.
    Kjellberg H; Wikland KA
    Eur J Orthod; 2007 Jun; 29(3):243-50. PubMed ID: 17513878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.